AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/46834/ihc_cell_selected_60x60.jpg) | ![](/images/46834/147523_A_8_6_rna_selected_60x60.jpg) | Tissue enriched |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/15278/155554_A_1_7_selected_60x60.jpg) | ![](/images/15278/141832_A_1_5_rna_selected_60x60.jpg) | Tissue enriched |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | Predicted intracellular proteins
| | ![](/images/58496/1364_D11_2_selected_60x60.jpg) | ![](/images/55327/ihc_cell_selected_60x60.jpg) | ![](/images/55327/131791_A_7_3_rna_selected_60x60.jpg) | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Predicted intracellular proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28701/146530_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7600/21592_A_9_2_rna_selected_60x60.jpg) | Tissue enriched |
BSND | Barttin CLCNK-type chloride channel accessory beta subunit | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/53836/ihc_cell_selected_60x60.jpg) | ![](/images/53836/123883_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
C9orf66 | Chromosome 9 open reading frame 66 | Predicted intracellular proteins
| ![](/images/35652/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35652/70075_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
CALB1 | Calbindin 1, 28kDa | Predicted intracellular proteins
| | | ![](/images/23099/154263_A_1_8_selected_60x60.jpg) | ![](/images/2138/151406_B_7_2_rna_selected_60x60.jpg) | Tissue enriched |
CDH16 | Cadherin 16, KSP-cadherin | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/36260/ihc_cell_selected_60x60.jpg) | ![](/images/13526/33086_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
CLCN5 | Chloride channel, voltage-sensitive 5 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images/401/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/401/666_A_7_4_rna_selected_60x60.jpg) | Tissue enriched |
CLCNKA | Chloride channel, voltage-sensitive Ka | Disease related genes Predicted membrane proteins
| ![](/images/57717/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57717/149085_A_1_6_rna_selected_60x60.jpg) | Tissue enriched |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/56020/144938_B_2_1_rna_selected_60x60.jpg) | Tissue enriched |
CLEC18A | C-type lectin domain family 18, member A | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/48976/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48976/137986_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CLEC18B | C-type lectin domain family 18, member B | Predicted secreted proteins
| ![](/images/48976/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48976/137986_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CLEC18C | C-type lectin domain family 18, member C | Predicted secreted proteins
| ![](/images/48976/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48976/137986_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CRYAA | Crystallin, alpha A | Disease related genes Plasma proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CRYAA | Crystallin, alpha A | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CRYBB3 | Crystallin, beta B3 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45293/102964_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
CTXN3 | Cortexin 3 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CYS1 | Cystin 1 | Cytoskeleton related proteins Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
EMX1 | Empty spiracles homeobox 1 | Predicted intracellular proteins Transcription factors
| ![](/images/6421/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6421/17986_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
FMO1 | Flavin containing monooxygenase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images/23680/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23680/53125_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
FXYD4 | FXYD domain containing ion transport regulator 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58421/147258_A_2_4_rna_selected_60x60.jpg) | Tissue enriched |
GALNT14 | Polypeptide N-acetylgalactosaminyltransferase 14 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images/10785/47_H11_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
GGACT | Gamma-glutamylamine cyclotransferase | Enzymes Predicted intracellular proteins
| ![](/images/65320/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/65320/148026_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
HMX2 | H6 family homeobox 2 | Predicted intracellular proteins Transcription factors
| ![](/images/43379/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43379/94341_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/26962/ihc_cell_selected_60x60.jpg) | ![](/images/26962/65936_A_1_1_rna_selected_60x60.jpg) | Tissue enriched |
KL | Klotho | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
LHX1 | LIM homeobox 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| ![](/images/2770/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2770/6966_B_1_4_rna_selected_60x60.jpg) | Tissue enriched |
MCCD1 | Mitochondrial coiled-coil domain 1 | Mitochondrial proteins Predicted secreted proteins
| ![](/images/46948/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46948/105139_B_9_8_rna_selected_60x60.jpg) | Tissue enriched |
MIOX | Myo-inositol oxygenase | Enzymes Predicted intracellular proteins
| | ![](/images/39562/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39451/146539_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | Enzymes Predicted membrane proteins
| ![](/images/45990/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45990/108199_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
NOX4 | NADPH oxidase 4 | Predicted membrane proteins Transporters
| ![](/images/15475/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15475/39091_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
NPHS2 | Nephrosis 2, idiopathic, steroid-resistant (podocin) | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/49486/ihc_cell_selected_60x60.jpg) | ![](/images/37267/71749_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
OR2T10 | Olfactory receptor, family 2, subfamily T, member 10 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/52019/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52019/119735_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
PRR35 | Proline rich 35 | Predicted intracellular proteins
| ![](/images/69297/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/69297/154346_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
PTH1R | Parathyroid hormone 1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/7978/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7978/21636_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
PVALB | Parvalbumin | Predicted intracellular proteins
| | ![](/images/48536/1413_F4_3_selected_60x60.jpg) | | ![](/images/48536/125132_B_3_7_rna_selected_60x60.jpg) | Tissue enriched |
RAB11FIP3 | RAB11 family interacting protein 3 (class II) | Cancer-related genes Predicted intracellular proteins
| ![](/images/28088/ihc_selected_60x60.jpg) | | | ![](/images/28088/60524_A_7_4_rna_selected_60x60.jpg) | Tissue enriched |
RNF152 | Ring finger protein 152 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/15733/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15733/37673_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
SIM1 | Single-minded family bHLH transcription factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images/18107/if_selected_60x60.jpg) | ![](/images/14967/ihc_cell_selected_60x60.jpg) | ![](/images/14967/33483_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28748/141823_A_3_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14736/33478_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC16A12 | Solute carrier family 16, member 12 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/37587/ihc_selected_60x60.jpg) | ![](/images/37587/1300_A3_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37587/75362_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| ![](/images/16569/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16569/38399_B_6_6_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/24575/ihc_cell_selected_60x60.jpg) | ![](/images/24575/56695_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/35603/146816_A_3_8_selected_60x60.jpg) | ![](/images/35603/72936_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68236/152461_A_7_8_rna_selected_60x60.jpg) | Tissue enriched |